We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.59B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+21.24%
3 Year Est. Return
+57.44%
5 Year Est. Return
+51.44%
10 Year Est. Return
AUM
$946M
AUM Growth
-$112M
Cap. Flow
+$39.6M
Cap. Flow %
4.18%
Top 10 Hldgs %
55.19%
Holding
241
New
27
Increased
96
Reduced
79
Closed
21

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.33%
2 Technology 1.64%
3 Healthcare 1.09%
4 Real Estate 0.95%
5 Financials 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
201
Boston Scientific
BSX
$69.3B
$227K 0.02%
+6,100
New +$248K
ACN icon
202
Accenture
ACN
$114B
$226K 0.02%
815
+72
+10% +$21.6K
SBUX icon
203
Starbucks
SBUX
$119B
$224K 0.02%
2,934
+92
+3% +$7.07K
PFF icon
204
iShares Preferred and Income Securities ETF
PFF
$12.9B
$220K 0.02%
+6,685
New +$226K
PARA
205
DELISTED
Paramount Global Class B
PARA
$212K 0.02%
8,607
-435
-5% -$13.3K
XLK icon
206
State Street Technology Select Sector SPDR ETF
XLK
$122B
$212K 0.02%
3,332
+784
+31% +$54.6K
GLDM icon
207
SPDR Gold MiniShares Trust
GLDM
$32.2B
$205K 0.02%
+5,700
New +$212K
PPL
208
PPL Corp
PPL
$26.4B
$203K 0.02%
7,471
QYLD icon
209
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.35B
$176K 0.02%
+10,055
New +$189K
BBDC icon
210
Barings BDC
BBDC
$944M
$95K 0.01%
+10,203
New +$104K
CYPH
211
Cypherpunk Technologies Inc
CYPH
$261M
$59K 0.01%
5,148
+259
+5% +$3.35K
PYR
212
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$47K 0.01%
24,197
+3,067
+15% +$6.52K
GMDA
213
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$45K ﹤0.01%
25,629
VSTM icon
214
Verastem
VSTM
$743M
$37K ﹤0.01%
2,631
+43
+2% +$685
HEPA
215
DELISTED
Hepion Pharmaceuticals
HEPA
$36K ﹤0.01%
62
SENS icon
216
Senseonics Holdings Inc
SENS
$509M
$26K ﹤0.01%
1,250
DM
217
DELISTED
Desktop Metal, Inc.
DM
$26K ﹤0.01%
1,184
+1,180
+29,500% +$34.5K
TTOO
218
DELISTED
T2 Biosystems, Inc
TTOO
$18K ﹤0.01%
23
SNDL icon
219
Sundial Growers
SNDL
$358M
$14K ﹤0.01%
4,403
+3,280
+292% +$14.5K
CRBP icon
220
Corbus Pharmaceuticals
CRBP
$214M
$3K ﹤0.01%
334
ABNB icon
221
Airbnb
ABNB
$107B
-1,316
Closed -$226K
AEM icon
222
Agnico Eagle Mines
AEM
$104B
-4,292
Closed -$263K
BNDX icon
223
Vanguard Total International Bond ETF
BNDX
$83.4B
-4,011
Closed -$210K
BX icon
224
Blackstone
BX
$102B
-1,607
Closed -$204K
CRL icon
225
Charles River Laboratories
CRL
$13.8B
-832
Closed -$236K

Similar funds

McAdam LLC's Q2 2022 Portfolio in Review

As of Q2 2022, McAdam LLC held 241 positions worth $946M, down 11% from $1.06B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

McAdam LLC deployed $39.6M of net new capital in Q2 2022, opening 27 new positions and adding to 96 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF June: 236,623 shares worth $6.88M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Schwab US Large- Cap ETF, an estimated $9.07M trimmed.

  • McAdam LLC's largest Q2 2022 buy was Innovator US Equity Power Buffer ETF June: 236,623 shares worth $6.88M.
  • McAdam LLC added most to Vanguard Short-Term Bond ETF in Q2 2022, an estimated $8.5M increase.
  • McAdam LLC's biggest Q2 2022 reduction was Schwab US Large- Cap ETF, cutting an estimated $9.07M.
  • McAdam LLC fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $470K.
  • McAdam LLC's ten largest holdings make up 55% of its $946M portfolio in Q2 2022.
  • McAdam LLC opened 27 new positions and closed 21 in Q2 2022.
  • McAdam LLC's portfolio value fell 11% quarter-over-quarter to $946M.

Based on McAdam LLC's 13F filing for Q2 2022, filed 15 Jul 2022.